Vaccine Sparking Immune Reaction Against Toxic Tau Proteins in Trial

Vaccine Sparking Immune Reaction Against Toxic Tau Proteins in Trial

313002

Vaccine Sparking Immune Reaction Against Toxic Tau Proteins in Trial

An investigation vaccine for Alzheimer’s disease, ACI-35.030 by AC Immune, induced a potent production of antibodies against toxic forms of tau protein — a Alzheimer’s hallmark — in patients with early stage disease, interim results of an ongoing Phase 1b/2a trial show. “These promising results … will be invaluable as we work to further ACI-35.030’s clinical development and ultimately fulfill the hopes of clinicians and patients for a therapy that could delay, or even prevent, the onset…

You must be logged in to read/download the full post.